Patents by Inventor Stephane Blais

Stephane Blais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10240043
    Abstract: The invention relates to a compound chosen from the compounds of formulae (I) and (II), the leucoforms thereof, the optical and geometrical isomers thereof and the tautomers thereof, and also the addition salts thereof with an acid or a base, and the solvates thereof. The invention also relates to the use of these particular compounds for dyeing keratin fibres.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: March 26, 2019
    Assignee: L'OREAL
    Inventors: Aziz Fadli, Stephane Blais
  • Publication number: 20170349753
    Abstract: The invention relates to a compound chosen from the compounds of formulae (I) and (II), the leucoforms thereof, the optical and geometrical isomers thereof and the tautomers thereof, and also the addition salts thereof with an acid or a base, and the solvates thereof. The invention also relates to the use of these particular compounds for dyeing keratin fibres.
    Type: Application
    Filed: December 17, 2015
    Publication date: December 7, 2017
    Inventors: Aziz FADLI, Stephane BLAIS
  • Publication number: 20050014816
    Abstract: The invention provides compounds of Formula (I), stereoisomers thereof, or pharmaceutically acceptable salts of said compounds or stereoisomers, wherein R1, R2, m, p, q, R7 and R8 are as defined below, as well as compositions comprising the same, processes for making the same, and methods of using the same to treat a variety of diseases, including, those requiring interaction with metalloproteases, and more specifically with macrophage metalloelastase (MMP-12), and for the prevention and treatment of respiratory pathologies such as chronic obstructive bronchopneumopathy (COPD), emphysema, chronic bronchitis, chronic pulmonary inflammation, asthma, cystic fibrosis, acute respiratory distress syndrome (ARDS), respiratory allergies including allergic rhinitis, and also diseases associated with the production of TNF? including severe fibrotic pulmonary disease, pulmonary sarcoidosis and silicosis.
    Type: Application
    Filed: July 2, 2004
    Publication date: January 20, 2005
    Inventors: Delphine Compere, Anne-Claude Dublanchet, Karine Courte, Stephane Blais, Pierre Ducrot, Philippe Cluzeau, Alexis Denis
  • Publication number: 20050014817
    Abstract: The invention provides compounds of Formula (I), stereoisomers thereof, or pharmaceutically acceptable salts of said compounds or stereoisomers wherein R1 and R2 are as defined herein as well as compositions comprising the same, processes for making the same, and methods of using the same to treat a variety of diseases, including, those requiring interaction with metalloproteases, and more specifically with macrophage metalloelastase (MMP-12), and for the prevention and treatment of respiratory pathologies such as chronic obstructive bronchopneumopathy (COPD), emphysema, chronic bronchitis, chronic pulmonary inflammation, asthma, cystic fibrosis, acute respiratory distress syndrome (ARDS), respiratory allergies including allergic rhinitis, and also diseases associated with the production of TNF? including severe fibrotic pulmonary disease, pulmonary sarcoidosis and silicosis.
    Type: Application
    Filed: July 2, 2004
    Publication date: January 20, 2005
    Inventors: Delphine Compere, Anne-Claude Dublanchet, Karine Courte, Stephane Blais
  • Publication number: 20040072871
    Abstract: A compound of formula (I) selected from: 1
    Type: Application
    Filed: August 8, 2003
    Publication date: April 15, 2004
    Inventors: Anne-Claude Dublanchet, Delphine Compere, Philippe Cluzeau, Stephane Blais, Alexis Denis, Pierre Ducrot, Karine Courte, Sophie Descamps